Verona Pharma plc ADR buy BiotechBee
Start price
07.09.22
/
60%
€10.30
Target price
31.12.25
€18.00
Performance (%)
77.67%
End price
05.05.23
€18.30
Summary
This prediction ended on 05.05.23 with a price of €18.30. With a performance of 77.67% the BUY prediction by BiotechBee was a big success. BiotechBee has a follow-up prediction for Verona Pharma plc ADR where he still thinks Verona Pharma plc ADR is a Buy. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Verona Pharma plc ADR | - | - | - |
iShares Core DAX® | -1.941% | -4.109% | 11.238% |
iShares Nasdaq 100 | -3.642% | -10.625% | 21.511% |
iShares Nikkei 225® | -2.728% | -6.434% | 8.146% |
iShares S&P 500 | -3.440% | -5.152% | 20.197% |
According to BiotechBee what are the pros and cons of Verona Pharma plc ADR for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Verona Pharma Plc diskutieren
Buy mit Kursziel 18,0
In the thread Trading Verona Pharma Plc
Buy beendet
Current prediction by BiotechBee for Verona Pharma plc ADR
Verona Pharma plc ADR
Start price
Target price
Perf. (%)
€19.10
24.06.23
24.06.23
€40.00
31.12.25
31.12.25
-7.85%
16:15
16:15
Could be very worthwhile Investment >20% year